Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Urology ; 143: 68-74, 2020 09.
Article in English | MEDLINE | ID: mdl-32540300

ABSTRACT

OBJECTIVES: To assess the financial impact of switching to single-use ureteroscopes (sURS) in urolithiasis management for a hospital, over a 5-year period, and to identify possible solutions to contain or reduce it. METHODS: A Budget Impact (BI) model was designed for a public hospital performing around 200 ureteroscopies or extracorporeal shockwave lithotripsies per year. The BI was estimated as the difference between financial balances (between costs and revenues) of 2 environments (with and without sURS). The population was defined as adults treated for urolithiasis. The BI model was based on assumptions about the expected progression in the incidence of urolithiasis, and the expected change in clinical practices due to the availability of sURS. We considered the costs and revenues of hospital stays, the purchase price of sURS and the costs of digital or fiberoptic reusable ureteroscopes (rURS). Univariate and multivariate sensitivity analyses were performed. RESULTS: The cumulative 5-year financial impact of switching completely to sURS was €807,824 and €649,677 in comparison with fiberoptic and digital rURS respectively. This impact could be reduced by half or more if the health-care facility were to adopt different solutions, including negotiating the purchase price of sURS, developing outpatient activity and reducing production costs for ureteroscopy procedures. CONCLUSION: The BI model gives decision-makers a more accurate picture of the financial impact of switching to sURS and highlights ways to reduce the expected additional cost.


Subject(s)
Cost Savings , Disposable Equipment/economics , Ureteroscopes/economics , Urolithiasis/economics , Urolithiasis/surgery , Equipment Design , France , Humans , Time Factors
2.
BJU Int ; 124(6): 1034-1039, 2019 12.
Article in English | MEDLINE | ID: mdl-31206221

ABSTRACT

OBJECTIVES: To evaluate the clinical, fiscal and environmental impact of a specialist-led acute ureteric colic virtual clinic (VC) pathway. PATIENTS AND METHODS: All patients with uncomplicated acute ureteric colic, referred to a single tertiary centre, were prospectively entered into the study over a 4-year period (January 2015-December 2018). Inclusion criteria were: low-dose non-contrast computed tomography of kidneys, ureters and bladder; white blood cell count <16 × 109/L; pain controlled; normal renal function; and no clinical concern. Primary outcomes were: time (days) from referral to VC outcome; VC outcome (discharge, further VC, face-to-face [FTF] clinic, extracorporeal shockwave lithotripsy [ESWL], ureterorenoscopy [URS], percutaneous nephrolithotomy [PCNL]); and adverse events (sepsis or obstruction). Secondary outcomes were patient and stone demographics, cost and environmental analysis. The minimum follow-up was 3 months. RESULTS: A total of 1008 patients entered the study, of whom 91.5% (n = 922) were of working age. The median (interquartile range) time from presentation to VC outcome was 2 (4) days. VC outcomes were as follows: 16.3% of patients (n = 164) were discharged; 18.2% (n = 183) were discharged after further VC; 17.2% (n = 173) underwent an intervention; and 48.4% (n = 488) were referred to an FTF clinic. Interventions comprised: PCNL 0.5% (n = 5); ESWL 7.7% (n = 78); and URS 8.9% (n = 90). Stone demographics were as follows: 570 patients (56.5%) had lower, 157 (15.6%) had upper, 96 (9.5%) had mid-ureteric and 163 (16.2%) had renal calculi, and in 22 patients (2.2%) the stones had recently passed. The mean (sd) stone size was 3.5  (2.3) mm. Two adverse events (0.2%) were reported. Introducing a VC saved £145,152 for Clinical Commissioning Groups, the equivalent NHS tariff payment of performing 106 URS procedures or 211 ureteric stent insertions. Overall, 15,085 patient journey kilometres were avoided, equal to 0.70-2.93 metric tonnes of carbon dioxide equivalent production and the need to plant 14.7 trees to achieve carbon balance. CONCLUSION: A specialist-led acute ureteric colic VC reduced time to treatment decision to a median of 2 days. This creates additional clinic capacity and reduces the fiscal burden of traditional clinics and their associated carbon footprint.


Subject(s)
Carbon Footprint , Renal Colic , Telemedicine , Adult , Carbon Footprint/economics , Carbon Footprint/statistics & numerical data , Costs and Cost Analysis , Female , Humans , Male , Middle Aged , Prospective Studies , Renal Colic/economics , Renal Colic/epidemiology , Renal Colic/therapy , Telemedicine/economics , Telemedicine/statistics & numerical data , Treatment Outcome , Urolithiasis/economics , Urolithiasis/epidemiology , Urolithiasis/therapy
3.
J Endourol ; 33(2): 71-78, 2019 02.
Article in English | MEDLINE | ID: mdl-30612446

ABSTRACT

Flexible ureteroscopy has become an important tool in the urologist's armamentarium. Until recently, reusable ureteroscopes were the only tools available to perform ureteroscopy. However, in recent years, single-use flexible and semirigid ureteroscopes have been developed as an alternative to reusable ureteroscopes. These disposable ureteroscopes were designed to mitigate problems associated with the use of reusable ureteroscopes, including the high costs related to ureteroscope acquisition, maintenance, processing, sterilization, and repairs. In this review, we provide an overview of currently available single-use flexible ureteroscopes, which include LithoVue, Uscope, NeoFlex, and Shaogang, as well as the Neoscope semirigid ureteroscope. The functional capabilities (deflection, irrigation, and optical properties) of each ureteroscope are also discussed.


Subject(s)
Fiber Optic Technology/instrumentation , Ureteroscopes/economics , Ureteroscopy/instrumentation , Urolithiasis/therapy , Canada , Disposable Equipment , Equipment Design , Fiber Optic Technology/economics , Humans , Ureteroscopy/economics , Urolithiasis/economics
4.
Eur Urol Focus ; 3(1): 18-26, 2017 02.
Article in English | MEDLINE | ID: mdl-28720363

ABSTRACT

CONTEXT: The recent evolution of management options for urolithiasis has presented a unique dilemma for the modern urologist. A comprehensive understanding of epidemiological trends along with current provider preferences in treating urinary stones would be beneficial. OBJECTIVE: To review trends in the prevalence, treatments, and costs of urolithiasis worldwide. EVIDENCE ACQUISITION: A literature review was performed using the MEDLINE database, the Cochrane Library Central search facility, Web of Science, and Google Scholar between 1986 and 2016. Keywords used for the search were "urolithiasis" and "prevalence; treatment; and cost". EVIDENCE SYNTHESIS: The incidence and prevalence of urinary stones are rising around the world, including regions that have historically had low rates of urolithiasis. Common theories explaining this trend involve climate warming, dietary changes, and obesity. Shockwave lithotripsy (SWL) has been the preferred mode of treatment since its introduction in the 1980s. However, ureteroscopy (URS) has become increasingly popular for small stones regardless of location because of lower recurrence rates and costs. Developing countries have been slower to adopt URS technology and continue to use percutaneous nephrolithotomy at a steady rate. CONCLUSIONS: URS has recently challenged SWL as the treatment modality preferred for small upper urinary tract stones. In some cases it is less expensive but still highly effective. As the burden of stone disease increases worldwide, appropriate selection of stone removal therapies will continue to play an important role and will thus require further investigation. PATIENT SUMMARY: Urinary stones are becoming more prevalent. Recent advances in technology have improved the management of this disease and have decreased costs.


Subject(s)
Health Care Costs/trends , Urolithiasis/epidemiology , Urolithiasis/therapy , Asia/epidemiology , Australia/epidemiology , Europe/epidemiology , Humans , Lithotripsy/economics , Lithotripsy/trends , Nephrolithotomy, Percutaneous/economics , Nephrolithotomy, Percutaneous/trends , North America/epidemiology , Prevalence , Recurrence , Ureteroscopy/economics , Ureteroscopy/trends , Urolithiasis/economics
5.
World J Urol ; 35(9): 1321-1329, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28108799

ABSTRACT

The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.


Subject(s)
Conservative Treatment/economics , Cost of Illness , Health Care Costs , Hospitalization/economics , Lithotripsy/economics , Nephrolithiasis/economics , Nephrostomy, Percutaneous/economics , Ureteral Calculi/economics , Cost-Benefit Analysis , Humans , Nephrolithiasis/therapy , Ureteral Calculi/therapy , Urolithiasis/economics , Urolithiasis/therapy
6.
Int J Surg ; 36(Pt D): 705-712, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27865972

ABSTRACT

BACKGROUND: Paediatric urolithiasis remains endemic in low resource countries. This review highlights the epidemiology, causation and management of urolithiasis in an Asian country in the context of emerging economies. METHODS: A literature review of recent articles with key words paediatric urolithiasis, developing countries, endemic stone disease, stone composition, metabolic risk factors, management of paediatric urolithiasis was undertaken and 51 relevant articles were selected with the main focus on experience of this center in managing stone disease in the last two decades. RESULTS: Prevalence of paediatric urolithiasis is high upto 15% affecting children under 15 years with male predominance. Bladder stones still constitutes 10-70% of the burden. Etiology remains unknown where 55% are considered idiopathic, 25% metabolic, 7% infection and 12% due to anatomical abnormalities. Hot climate, poor nutrition, diarrheal diseases are the major causative factors. Chemical composition of stones showed CaOX in 30-63%, AAU in 17-55%, struvite in 8-9%, uric acid in 3-6% and cystine in 1%. Important metabolic risk factors are hypocitraturia in 63-87%, hyperoxaluria in 40-43%, hypocalciuria in 20%, hyperuricosuria in 27%, hyperammonuria in 11-51% and hypovolemia in 31%. Minimally invasive surgery is the mainstay of surgical management. ESWL provides excellent free rates of 84% for smaller stones. PCNL is the option for majority of renal stones with success rates of 89% for simple and 71.5% for complex stones. For bladder stones PUCL and PCCL success rates were 100%. URS for ureteric stones showed clearance rate of 90%. Open surgery is required in 12% of patients with large stone burden. CONCLUSION: Paediatric urolithiasis remains a devastating health problem in low resource settings. MIS offers relief to majority of patients with excellent stone free rates and short hospital stay. Preventable strategies have to be put in place by improving nutrition and eliminating risk factors by diet and medical intervention.


Subject(s)
Cost of Illness , Health Care Costs , Urolithiasis/economics , Child , Costs and Cost Analysis , Humans
7.
Urology ; 94: 208-13, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27208819

ABSTRACT

OBJECTIVE: To identify longitudinal trends of economic impact and resource utilization for management of pediatric urolithiasis using national databases. METHODS: We analyzed the 2006-2012 Nationwide Emergency Department Sample and Nationwide Inpatient Sample. We used ICD-9 (International Classification of Diseases) codes to identify patients (≤18 years) diagnosed with urolithiasis. Diagnostic imaging and surgeries were identified using ICD-9 and Current Procedural Technology codes. We abstracted demographic, imaging, procedure, and charge data. Weighted descriptive statistics were calculated to describe the population's demographics and economic expenditures by clinical setting and year. RESULTS: In total, 45,333 inpatient admissions (68% females) and 234,559 emergency department encounters (63% females) were identified. Most patients (84%) were teenagers and the southern region of the United States was the most common geographic region for all encounters (44%). There was no significant trend in number of urolithiasis encounters over the period studied. Utilization of all imaging techniques increased; in particular, computed tomography was used in 23% of encounters in 2006 and 40% in 2012 (P < .0001). The mean charge per emergency department visit increased by 60% from $3645 in 2006 to $5827 in 2012 (P < .0001). The mean charge increased for inpatient admissions by 102%, from $16,399 in 2006 to $33,205 in 2012 (P < .0001). Total charges increased 72% over the study period from $230 million in 2006 to $395 million in 2012 (P < .0001), outpacing medical inflation over the same period. CONCLUSION: Charges for pediatric urolithiasis management increased by 65% from 2006 to 2012 despite stable frequency of patient encounters. The utilization of computerized tomography in pediatric urolithiasis increased as well.


Subject(s)
Urolithiasis/diagnostic imaging , Urolithiasis/economics , Adolescent , Child , Child, Preschool , Diagnostic Imaging/economics , Diagnostic Imaging/statistics & numerical data , Female , Health Care Costs , Health Resources/statistics & numerical data , Health Resources/trends , Humans , Infant , Infant, Newborn , Male , United States
8.
Curr Opin Urol ; 26(1): 70-5, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26555688

ABSTRACT

PURPOSE OF REVIEW: Ureteral access sheath (UAS) became increasingly popular worldwide. However, the safety of its routine use remains controversial. The aim of the current revision is to provide a systematic review on the benefits and disadvantages of the UAS. RECENT FINDINGS: A systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Two reviewers independently searched the literature, finally identifying 20 articles valuable for this review. The use of UAS demonstrated several advantages to facilitate retrograde intrarenal access, lower intrarenal pressure, protect the ureter, protect the scope, and expedite stone extraction. Despite this, there is also some evidence that UAS use may be associated with acute ureteral injury and long-term complications, apparently related to maneuvers for UAS insertion and mucosal or deeper layers of injury and ischemia. Furthermore, there are still pending questions on the possible increase in stone-free rates, and decrease in operative time and costs. SUMMARY: Although the use of UAS is associated with some risk and limiting factors, it appears from this systematic review that its use is common and safe for the retrograde intrarenal access. Therefore, UAS is highly recommended for the treatment of upper tract disease by means of retrograde intrarenal surgery.


Subject(s)
Ureter/surgery , Ureteroscopy/instrumentation , Urolithiasis/surgery , Cost-Benefit Analysis , Equipment Design , Health Care Costs , Humans , Postoperative Complications/etiology , Risk Factors , Treatment Outcome , Ureter/injuries , Ureter/physiopathology , Ureteroscopy/adverse effects , Ureteroscopy/economics , Urolithiasis/diagnosis , Urolithiasis/economics , Urolithiasis/physiopathology
9.
Am J Obstet Gynecol ; 213(5): 691.e1-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26215329

ABSTRACT

OBJECTIVE: The purpose of this study was to determine the cost-effectiveness of serial stenting vs ureteroscopy for treatment of urolithiasis during pregnancy as a function of gestational age (GA) at diagnosis. STUDY DESIGN: We built decision analytic models for a hypothetical cohort of pregnant women who had received a diagnosis of symptomatic ureteral calculi and compared serial stenting to ureteroscopy. We assumed ureteral stent replacement every 4 weeks during pregnancy, intravenous sedation for stent placement, and spinal anesthetic for ureteroscopy. Outcomes were derived from the literature and included stent infection, migration, spontaneous kidney stone passage, ureteral injury, failed ureteroscopy, postoperative urinary tract infection, sepsis, and anesthetic complications. Four separate analyses were run based on the GA at diagnosis of urolithiasis. Using direct costs and quality-adjusted life years, we reported the incremental costs and effectiveness of each strategy based on GA at kidney stone diagnosis and calculated the net monetary benefit. We performed 1-way and Monte-Carlo sensitivity analyses to assess the strength of the model. RESULTS: Ureteroscopy was less costly and more effective for urolithiasis, irrespective of GA at diagnosis. The incremental cost of ureteroscopy increased from -$74,469 to -$7631, and the incremental effectiveness decreased from 0.49 to 0.05 quality-adjusted life years for a kidney stone diagnosed at 12 and 36 weeks of gestation, respectively. The net monetary benefit of ureteroscopy progressively decreased for kidney stones that were diagnosed later in pregnancy. The model was robust to all variables. CONCLUSION: Ureteroscopy is less costly and more effective relative to serial stenting for urolithiasis, regardless of the GA at diagnosis. Ureteroscopy is most beneficial for women who received the diagnosis early during pregnancy.


Subject(s)
Pregnancy Complications/therapy , Stents , Ureteroscopy , Urolithiasis/therapy , Cost-Benefit Analysis , Decision Support Techniques , Female , Foreign-Body Migration/epidemiology , Humans , Pregnancy , Pregnancy Complications/economics , Stents/economics , Ureteroscopy/adverse effects , Ureteroscopy/economics , Urolithiasis/economics
10.
J Urol ; 193(5 Suppl): 1855-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25305358

ABSTRACT

PURPOSE: The incidence of urolithiasis is increasing in children and adolescents but the economic impact of this problem is unclear. We examined 2 large databases to estimate the nationwide economic impact of pediatric urolithiasis. MATERIALS AND METHODS: We analyzed the 2009 NEDS and KID, used ICD-9-CM codes to identify children 18 years or younger diagnosed with urolithiasis and abstracted demographic and charge data from each database. RESULTS: We identified 7,348 weighted inpatient discharges in KID and 33,038 emergency department weighted encounters in NEDS. Of the patients 32% and 36% were male, respectively. Inpatients were younger than those who presented to the ED (mean age 13.9 vs 15.7 years). Most patients had private insurance (52.9% to 57.2%) and the South was the most common geographic region (39.5% to 44.4%). The most common procedures were ureteral stent placement in 20.4% to 24.1% of cases, followed by ureteroscopy in 3.8% to 4.4%. Median charges per admission were $13,922 for a weighted total of $229 million per year. Median emergency department charges were $3,991 per encounter for a weighted total of $146 million per year. CONCLUSIONS: Each day in 2009 in the United States an estimated 20 children were hospitalized and 91 were treated in the emergency department for upper tract stones. A conservative estimate of 2009 annual charges related to pediatric urolithiasis in the United States is at least $375 million. This is likely a significant underestimate of the true economic burden of pediatric urolithiasis because it accounts for neither outpatient management nor indirect costs such as caregiver time away from work.


Subject(s)
Cost of Illness , Urolithiasis/economics , Urolithiasis/epidemiology , Adolescent , Emergency Service, Hospital/economics , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Length of Stay , Male , Stents , United States/epidemiology , Ureteroscopy , Urolithiasis/therapy
11.
Urology ; 85(1): 216-20, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25530385

ABSTRACT

OBJECTIVE: To investigate the trends of newly diagnosed incidence, medical utilization, and medical costs for pediatric urolithiasis in Taiwan. MATERIALS AND METHODS: The present study uses the National Health Insurance Research Database, which contains the data of all medical benefit claims from the individuals enrolled in the national and single-payer insurance program in Taiwan. The National Health Insurance covered 22,717,053 enrollees, nearly 99% of Taiwan's population. Our analysis includes all subjects aged <18 years with a primary diagnosis of urolithiasis. We analyzed the temporal trend for annual newly diagnosed incidence, medical care visits, and medical costs for pediatric urolithiasis from 1998 to 2007. RESULTS: A total of 1474 patients aged <18 years with newly diagnosed urolithiasis were identified, including 719 (48.8%) boys and 755 (51.2%) girls. The overall newly diagnosed rate of urolithiasis in pediatric population was 0.038% in 2007. The peak age stratum of urolithiasis occurrence in 2007 was 15-18 years. The trend of annual newly diagnosed incidences for boys, girls, and all children declined from 1998 to 2007. Furthermore, there were declining trends both in medical costs and annual medical care visits during the study period. CONCLUSION: This is the first nationwide population-based study to indicate the declining trends in newly diagnosed rate, medical care visits, and medical costs for pediatric urolithiasis. These findings help to quantify and establish the burden of pediatric urolithiasis. These findings help to quantify and establish the burden of medical care for pediatric urolithiasis and to further refine the medical policy.


Subject(s)
Urolithiasis , Adolescent , Child , Child, Preschool , Costs and Cost Analysis , Female , Health Services/statistics & numerical data , Humans , Incidence , Infant , Male , Retrospective Studies , Taiwan/epidemiology , Time Factors , Urolithiasis/diagnosis , Urolithiasis/economics , Urolithiasis/epidemiology , Urolithiasis/therapy
13.
Pediatr Nephrol ; 30(5): 805-10, 2015 May.
Article in English | MEDLINE | ID: mdl-25481020

ABSTRACT

BACKGROUND: The goal of this study was to examine national trends in hospitalization, emergency department (ED) utilization, secondary diagnoses, and charges associated with pediatric urolithiasis. METHODS: Data were evaluated from the Kids' Inpatient Database of the Healthcare Costs and Utilization Project (HCUP) database from 1997 to 2012 and the HCUP National ED Sample from 2006 to 2011. RESULTS: Pediatric nephrolithiasis discharges increased by 18%, while ureterolithiasis discharges decreased by 17%. Hospital charges increased by 20% when accounting for inflation, despite an overall decrease in discharges by 2.5%. Female patients and those aged 15-17 years were more commonly affected. Pediatric ED visits increased by 9%. The most common secondary diagnoses during 2003-2009 were urinary tract infections (UTI) (13%), asthma (9%), epilepsy (4%), and paralysis (4%). CONCLUSIONS: Decreased hospitalizations and increased ED visits indicate a shift to outpatient care. Inpatient health care charges associated with pediatric urolithiasis continue to rise. Comorbidities include UTI, asthma, epilepsy, attention deficit hyperactivity disorder (ADHD), and mood disorders. Because of the significant health care burden and the increased risk to children of developing long-term sequelae there is a strong need for increased research into the mechanism of this systemic inflammatory disease and improved therapeutic targets.


Subject(s)
Health Care Costs/trends , Urolithiasis/economics , Urolithiasis/epidemiology , Adolescent , Child , Comorbidity , Emergency Service, Hospital/economics , Emergency Service, Hospital/trends , Female , Hospitalization/economics , Hospitalization/trends , Humans , Male , Pediatrics/economics , Pediatrics/trends
15.
Eur Urol ; 66(4): 724-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25015037

ABSTRACT

BACKGROUND: The prevalence of urolithiasis and its risk factors such as obesity and diabetes have increased over time. OBJECTIVE: Determine the future cost and prevalence of kidney stones using current and projected estimates for stones, obesity, diabetes, and population rates. DESIGN, SETTING, AND PARTICIPANTS: The stone prevalence in 2000 was estimated from the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 2007-2010. The cost per percentage prevalence of stones in 2000, calculated using Urologic Diseases in America Project data, was used to estimate the annual cost of stones in 2030, adjusting for inflation and increases in population, stone prevalence, obesity and diabetes rates. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was prevalence and cost of stones in 2030. The secondary outcomes were the impact of obesity and diabetes on these values, calculated using odds ratios for stones by body mass index and diabetes status. RESULTS AND LIMITATIONS: The annual cost of stone disease in 2000, adjusted for inflation to 2014 US dollars, was approximately $2.81 billion. After accounting for increases in population and stone prevalence from 2000, the estimated cost of stones in 2007 in 2014 US dollars was $3.79 billion. Future population growth alone would increase the cost of stone disease by $780 million in 2030. Based on projected estimates for 2030, obesity will independently increase stone prevalence by 0.36%, with an annual cost increase of $157 million. Diabetes will independently increase stone prevalence by 0.72%, associated with a cost increase of $308 million annually by 2030. NHANES data, however, capture patient self-assessment rather than medical diagnosis, which is a potential bias. CONCLUSIONS: The rising prevalence of obesity and diabetes, together with population growth, is projected to contribute to dramatic increases in the cost of urolithiasis, with an additional $1.24 billion/yr estimated by 2030. PATIENT SUMMARY: Obesity, diabetes, and population rates will contribute to an estimated $1.24 billion/yr increase in the cost of kidney stones by 2030.


Subject(s)
Diabetes Mellitus/epidemiology , Health Care Costs , Obesity/epidemiology , Urolithiasis/economics , Urolithiasis/epidemiology , Age Distribution , Aged , Body Mass Index , Comorbidity , Diabetes Mellitus/diagnosis , Female , Humans , Kidney Calculi/diagnosis , Kidney Calculi/economics , Kidney Calculi/epidemiology , Male , Middle Aged , Nutrition Surveys , Obesity/diagnosis , Prevalence , Risk Assessment , Severity of Illness Index , Sex Distribution , United States/epidemiology , Urolithiasis/diagnosis
16.
J Urol ; 191(1): 90-6, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23933053

ABSTRACT

PURPOSE: Using the Nationwide Emergency Department Sample (NEDS) we examined trends in visits, hospitalization and charges for patients with upper urinary tract stones who presented to the emergency department in the United States. MATERIALS AND METHODS: All visits with a primary diagnosis of kidney calculus (ICD-9-CM code 592.0), ureter calculus (592.1) or urinary calculus unspecified (592.9) were extracted from NEDS between 2006 and 2009. A weighted sample was used to calculate incidence rates. Temporal trends were quantified by the estimated annual percent change. Patient and hospital characteristics associated with hospitalization were evaluated using logistic regression models adjusted for clustering. RESULTS: Between 2006 and 2009 there were 3,635,054 emergency department visits for upper urinary tract stones. The incidence increased from 289 to 306/100,000 individuals. More men visited than women but women showed significant increases in visits (estimated annual percent change 2.85%, p = 0.018). Total monthly emergency department visits ranged from 5.8% in February to 8.4% in August. Overall 12.0% of patients were hospitalized and the hospitalization rate remained stable (estimated annual percent change -1.02%, p = 0.634). Patients were more likely to be hospitalized if they were female, more ill, seen at an urban teaching or low volume hospital, or had Medicaid or Medicare (each p <0.001). Sepsis was associated with the highest likelihood of hospital admission (OR 69.64, p <0.001). In 2009 charges for emergency department visits increased to $5 billion (estimated annual percent change 10.06%, p = 0.003). CONCLUSIONS: Women showed significant annual increases in emergency department visits for upper urinary tract stones. While emergency department charges increased substantially, hospitalization rates remained stable. Greater use of computerized tomography and medical expulsive therapy could be the reasons for this observation, which warrants further study.


Subject(s)
Emergency Service, Hospital/statistics & numerical data , Hospitalization/trends , Urolithiasis/economics , Urolithiasis/epidemiology , Adult , Emergency Service, Hospital/economics , Fees and Charges/statistics & numerical data , Female , Hospitalization/economics , Humans , Kidney Calculi/economics , Kidney Calculi/epidemiology , Male , Middle Aged , United States/epidemiology , Ureterolithiasis/economics , Ureterolithiasis/epidemiology
17.
J Endourol ; 27(12): 1535-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24251430

ABSTRACT

BACKGROUND AND PURPOSE: We sought to examine a large nationwide (United States) sample of emergency department (ED) visits to determine data related to utilization and costs of care for urolithiasis in this setting. METHODS: Nationwide Emergency Department Sample was analyzed from 2006 to 2009. All patients presenting to the ED with a diagnosis of upper tract urolithiasis were analyzed. Admission rates and total cost were compared by region, hospital type, and payer type. Numbers are weighted estimates that are designed to approximate the total national rate. RESULTS: An average of 1.2 million patients per year were identified with the diagnosis of urolithiasis out of 120 million visits to the ED annually. Overall average rate of admission was 19.21%. Admission rates were highest in the Northeast (24.88%), among teaching hospitals (22.27%), and among Medicare patients (42.04%). The lowest admission rates were noted for self-pay patients (9.76%) and nonmetropolitan hospitals (13.49%). The smallest increases in costs over time were noted in the Northeast. Total costs were least in nonmetropolitan hospitals; however, more patients were transferred to other hospitals. When assessing hospital ownership status, private for-profit hospitals had similar admission rates compared with private not-for-profit hospitals (16.6% vs 15.9%); however, costs were 64% and 48% higher for ED and inpatient admission costs, respectively. CONCLUSIONS: Presentation of urolithiasis to the ED is common, and is associated with significant costs to the medical system, which are increasing over time. Costs and rates of admission differ by region, payer type, and hospital type, which may allow us to identify the causes for cost discrepancies and areas to improve efficiency of care delivery.


Subject(s)
Emergency Service, Hospital/economics , Hospital Costs , Patient Admission/statistics & numerical data , Urolithiasis/economics , Costs and Cost Analysis , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Incidence , Male , Medicare/economics , Middle Aged , Retrospective Studies , United States/epidemiology , Urolithiasis/epidemiology
18.
J Urol ; 190(3): 882-7, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23517746

ABSTRACT

PURPOSE: The use of medical expulsive therapy to hasten stone passage potentially decreases expenditures around episodes of renal colic. However, these efficiency gains may be mitigated if patients treated with medical expulsive therapy have frequent health care encounters due to pain while waiting for the stones to pass. MATERIALS AND METHODS: Using claims data (2002 to 2006) we identified adult men with acute renal colic. We compared 6-week payments as well as frequency of hospitalization and emergency department revisits associated with an initial course of medical expulsive therapy with those for early endoscopic stone removal. To account for unmeasured confounding we performed an instrumental variable analysis, exploiting variation in recommended treatments based on the day of the week that a patient's first emergency department visit occurred. RESULTS: Overall 1,835 and 4,397 men underwent medical expulsive therapy or early endoscopic stone removal, respectively. Although minimal differences existed between men with respect to the day of the week of emergency department presentation, weekend encounters were strongly associated with receiving medical expulsive therapy (p <0.001). Two-stage least squares regression revealed 6-week payments to be tenfold lower for men on medical expulsive therapy who were candidates for either treatment (p <0.001). While there was no difference in frequency of hospitalization, these men were more likely to have a repeat emergency department visit compared to those who underwent endoscopic stone removal (68.8% vs 39.6%, respectively, p = 0.025). CONCLUSIONS: Findings on medical expulsive therapy are mixed, with lower 6-week payments but more frequent repeat emergency department visits. These data inform patients who are candidates for medical expulsive therapy or endoscopic stone removal when making decisions about their care.


Subject(s)
Cost of Illness , Emergency Service, Hospital/economics , Endoscopy/economics , Renal Colic/economics , Adrenergic alpha-Antagonists/economics , Adrenergic alpha-Antagonists/therapeutic use , Adult , Calcium Channel Blockers/economics , Calcium Channel Blockers/therapeutic use , Cohort Studies , Cost-Benefit Analysis , Databases, Factual , Emergency Service, Hospital/statistics & numerical data , Endoscopy/methods , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Kidney Calculi/diagnosis , Kidney Calculi/drug therapy , Kidney Calculi/economics , Kidney Calculi/surgery , Male , Middle Aged , Renal Colic/drug therapy , Renal Colic/surgery , Retrospective Studies , Urolithiasis/drug therapy , Urolithiasis/economics , Urolithiasis/surgery
19.
Curr Urol Rep ; 14(2): 154-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23371486

ABSTRACT

The prevalence of kidney stones is rising rapidly in the United States. Data from the Urologic Diseases in America project suggests that healthcare utilization and expenditures for treating patients with kidney stones are rising dramatically as well. Current understanding of treatment patterns is limited, but suggests that urologists are moving away from shock-wave lithotripsy and towards ureteroscopy for urinary stones that require intervention. Many opportunities exist for furthering our understanding of healthcare delivery for stones, including assessing quality of care, drivers of expenditures, and opportunities to maximize value for patients.


Subject(s)
Practice Patterns, Physicians'/statistics & numerical data , Urolithiasis/therapy , Health Care Costs , Health Services/economics , Health Services/statistics & numerical data , Humans , Lithotripsy , Nephrostomy, Percutaneous , Practice Patterns, Physicians'/economics , Treatment Outcome , United States , Ureteroscopy , Urolithiasis/economics
20.
Urol Clin North Am ; 40(1): 129-33, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23177640

ABSTRACT

Kidney stone disease is rising in prevalence in the United States and abroad, and the cost burden of this condition is substantial. Although cost-effectiveness considerations are typically made by policymakers, individual practitioners have become increasingly involved in these discussions, to affect the rising costs of care and to assert control of treatment options. This article reviews existing literature regarding the cost-effectiveness of medical and surgical treatments for stone disease and identifies areas in which additional investigation is needed.


Subject(s)
Guidelines as Topic , Health Care Costs , Urolithiasis/economics , Urolithiasis/therapy , Urology/economics , Urology/methods , Cost-Benefit Analysis , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...